NCT06662812View on ClinicalTrials.gov

Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery Registry

CompletedOBSERVATIONAL

Enrollment

1,665

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions

Sickle Cell Disease

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY